Defense Is the Story of 2026. Here Are 2 Stocks to Own All Year.

Rocket Lab highlighted a $190 million hypersonic test-flight contract and a $90 million Space Force satellite development award, underscoring growing defense exposure. AeroVironment is benefiting from defense demand, with $1.1 billion in funded backlog and $3 billion in unfunded backlog, plus a 2026 adjusted EPS forecast of $2.75 to $3.10. The article is broadly positive on both names, though it is mainly investment commentary rather than fresh market-moving news.

Analysis

The market is beginning to re-rate defense beyond legacy primes toward “picks-and-shovels” exposure to autonomous warfare and space-domain infrastructure. That is structurally bullish for RKLB and AVAV because both sit closer to incremental budget growth than to replacement spending: Rocket Lab is becoming a mission-enabling launch/satellites platform, while AeroVironment is positioned to capture the fastest-growing slice of procurement where attritable systems, sensing, and software scale faster than manned platforms. Second-order effect: the winners are not just these names, but also their upstream suppliers in avionics, propulsion, sensors, and contract manufacturing; the losers are slower-moving traditional primes that need longer program cycles and face margin pressure as budgets tilt toward modular, repeatable products.

The biggest overlooked point is timing mismatch between headline geopolitics and budget conversion. Conflict risk can move the stocks in days, but contract revenue and backlog conversion are a months-to-years story; that means these equities can still underperform on a calm headline tape even if the strategic thesis remains intact. For RKLB, the key catalyst is not simply more launches, but proof that HASTE and Neutron together create a durable government platform franchise; if medium-lift execution slips, the market will punish the multiple because current valuation already embeds execution credibility. For AVAV, the hidden upside is production throughput: incremental facility expansion can drive margin expansion if demand stays elevated, but it also raises fixed-cost risk if program awards arrive slower than planned.

The contrarian view is that the trade may be too crowded on “drone war” and “space defense” narratives, while the actual budget winner could be larger integrated systems vendors or classified incumbents with deeper procurement relationships. AVAV’s backlog is impressive, but a meaningful share is timing-sensitive and can stretch out if appropriations, export approvals, or customer inventory digestion slow. For RKLB, defense optionality is real, but it is still a capital-intensive platform story; if sentiment turns risk-off, the market will value it more like a pre-profit industrial than a pure defense comp, compressing the multiple quickly. The right lens is not just growth, but conversion quality: the best risk/reward comes from names that can turn hype into recurring government-funded utilization within the next 2-4 quarters.

Key Decisions for Investors

• Go long AVAV on pullbacks over the next 2-6 weeks; better risk/reward than RKLB because funded backlog plus profitability reduces dilution risk, and any Golden Dome-related award can rerate the stock 15-25% on announcement.
• Use RKLB as a tactical long only into contract/news catalysts; size smaller than AVAV because the upside is larger if Neutron/HASTE traction compounds, but the downside is also larger if execution slips or risk appetite fades.
• Pair trade: long AVAV / short a slower-moving traditional defense prime basket for 3-6 months; thesis is budget mix shift toward autonomous systems and faster procurement cycles, with potential 10-15% relative outperformance if drone adoption stays hot.
• For higher-risk accounts, buy RKLB Jan-2027 calls or call spreads on weakness; this captures the multi-quarter re-rating if defense revenue meaningfully scales, while capping capital at risk if launch cadence disappoints.
• Take profits into geopolitical spikes rather than chasing them: both names are better owned on budget/process catalysts than on one-day conflict headlines, which typically mean-revert within days while contract flow takes months.